Pramipexole, a dopamine D2 autoreceptor agonist, decreases the extracellular concentration of dopamine in vivo
- 23 July 1991
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 200 (1) , 65-72
- https://doi.org/10.1016/0014-2999(91)90666-e
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- D-2 dopamine autoreceptor selective drugs: Do they really exist?Life Sciences, 1990
- B-HT 920 is a full agonist at both pre- and postsynaptic D-2 dopamine receptorsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1990
- Decrease of prolactin secretion via stimulation of pituitary dopamine D-2 receptors after application of talipexole and SND 919European Journal of Pharmacology, 1990
- Dopamine D-2 agonists with high and low efficacies: differentiation by behavioural techniquesJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1990
- Brain MicrodialysisJournal of Neurochemistry, 1989
- Effects of locally applied D-1 and D-2 receptor agonists and antagonists studied with brain dialysisEuropean Journal of Pharmacology, 1988
- Stimulation of D1dopamine receptors reveals direct effects of the preferential dopamine autoreceptor agonist B‐HT 920 on postsynaptic dopamine receptorsActa Physiologica Scandinavica, 1988
- Regional Cerebral Glucose Phosphorylation and Blood Flow After Insertion of a Microdialysis Fiber Through the Dorsal Hippocampus in the RatJournal of Neurochemistry, 1987
- Dopamine receptor agonists: Intrinsic activity vs. state of receptorJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1983
- Effects of B‐HT 920 and B‐HT 933 on Dopamine and Noradrenaline Autoreceptors in the Rat BrainActa Pharmacologica et Toxicologica, 1983